Re: "Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study"
Am J Epidemiol
.
2013 Apr 15;177(8):864-5.
doi: 10.1093/aje/kwt043.
Epub 2013 Mar 22.
Authors
Holly Janes
,
Margaret Pepe
PMID:
23524037
PMCID:
PMC3668426
DOI:
10.1093/aje/kwt043
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Cardiovascular Diseases / etiology*
Female
Humans
Male
Grants and funding
R01 CA152089/CA/NCI NIH HHS/United States
R01 GM054438/GM/NIGMS NIH HHS/United States
GM 54438/GM/NIGMS NIH HHS/United States
R01CA152089/CA/NCI NIH HHS/United States